The Law Office of Abe Shainberg is investigating the Board of Directors of Cephalon, Inc. (Nasdaq: CEPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA). Under the terms of the proposed transaction, Cephalon shareholders will receive $81.50 in cash per share for a transaction that has a total enterprise value of approximately $6.8 billion.

The investigation concerns whether the Cephalon Board of Directors breached their fiduciary duties to Cephalon stockholders by failing to adequately shop the Company before entering into this transaction and whether Teva Pharmaceutical Industries Ltd. is underpaying for Cephalon shares. According to Yahoo! Finance, at least one analyst placed a price target for Cephalon stock at $92 per share.

If you own common stock in Cephalon and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at as@ashainberglaw.com or by telephone at (212) 425-7286, or visit http://www.ashainberglaw.com/cephalon-ceph.html.

Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Cephalon Charts.
Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Cephalon Charts.